According to CNBC, Josh Brown said Moderna and Delta Air Lines had pulled back from recent highs and outlined trade levels for both stocks. Moderna fell 17% over four sessions after reaching $281 on Nov. 9, closing Friday at $223. Brown identified $202 as a potential trader stop and $180 as an investor reference level. Moderna’s Q3 revenue rose 29% to $1.31 billion, and the company posted a 38-cent-per-share profit, compared with a 51-cent loss a year earlier. Delta rose to $93 within a week of breaking out of its trading range on Nov. 4, then closed Friday at $86. Brown said a move back above $90 would strengthen the setup and cited $80 as a potential trader stop and $74 as an investor reference level. Delta reported record Q3 adjusted revenue of $17.6 billion, up 16%, and adjusted EPS of $1.72, compared with $1.70 a year earlier.